Stunner LNP Characterization

Importance of the Topic

Lipid nanoparticles (LNPs) are critical carriers for nucleic acid therapeutics and vaccines. Precise characterization of LNP size, concentration, aggregation state and payload loading ensures product efficacy, safety and reproducibility. Rapid, high-throughput analytics streamline formulation screening, process development and quality control in biopharmaceutical research and manufacturing.

Objectives and Overview of the Study

This application note introduces the Stunner system for unified LNP characterization. Key objectives include:

• Simultaneous measurement of UV/Vis concentration, dynamic light scattering (DLS), rotating angle DLS (RADLS) and multi-angle light scattering on a 2 µL sample.
• Quantification of particle size distribution, polydispersity, concentration, aggregation and total RNA payload in a single automated workflow.
• Demonstration of compatibility with high-throughput screening and automation for formulation development.

Methodology and Instrumentation Used

The Stunner platform employs a microfluidic plate with dual pathlengths (0.1 mm, 0.7 mm) to cover a 0.03–275 OD dynamic range. Core analytical techniques include:

• UV/Vis spectroscopy (230–750 nm) using a xenon flash lamp for concentration, turbidity correction and RNA absorbance via Unmix.
• DLS and RADLS with 660 nm laser diodes and avalanche photodiodes, collecting scattering data across up to 30 angles for hydrodynamic diameter and mass-weighted distributions.
• Automated handling of 96-well plates: ~10 min for UV/Vis only, ~1 h for UV/Vis plus single-angle DLS, ~2 h for full UV/Vis and RADLS multi-angle measurements.

Key Results and Discussion

The Stunner system delivers:

• Accurate sizing of LNP populations (0.3–1000 nm) with ≤2% size accuracy and polydispersity assessment.
• Particle concentration measurements over 10⁹–5×10¹³ particles/mL, enabling verification after dilutions.
• Detection of aggregates via intensity distributions, with mass distributions quantifying aggregate mass fraction.
• Turbidity-corrected UV/Vis spectra isolating RNA absorbance (A260) to calculate molecules per particle.
• Integration with Sunscreen formulation automation to generate and screen 96 LNP formulations in ~7 h, correlating flow rate with size, concentration and RNA loading.

Benefits and Practical Applications

Unified UV/Vis and light scattering analysis offers:

• Minimal sample volume (2 µL) and no dilution steps, reducing reagent consumption.
• High throughput screening for formulation selection, stability assessment and scale-up studies.
• Compliance with regulatory standards (USP, Ph. Eur., 21 CFR §11) for performance verification.
• Real-time monitoring of critical quality attributes (CQAs) during formulation and manufacturing.

Future Trends and Potential Applications

Emerging directions include:

• AI-driven data analysis for predictive formulation design and process optimization.
• Extension to diverse nanoparticle systems (liposomes, polymeric carriers) and complex biological matrices.
• Miniaturization and multiplexing to integrate additional modalities (e.g. zeta potential, fluorescence).
• Cloud-based platforms for collaborative data sharing and regulatory traceability.

Conclusion

The Stunner platform consolidates critical analytical measurements into a single, automated workflow, enabling comprehensive LNP characterization with minimal sample volume and high throughput. Its integration of UV/Vis, DLS and multi-angle scattering accelerates formulation development, process optimization and quality control for LNP-based therapeutics.

References

• Unchained Labs. Stunner instrument specifications and application note, Rev B, 2024.